Form 8-K - Current report:
SEC Accession No. 0001021771-25-000113
Filing Date
2025-08-12
Accepted
2025-08-12 16:16:41
Documents
17
Period of Report
2025-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q2 2025 EARNINGS, BUSINESS UPDATE AND CONFERENCE CALL brt81225.htm   iXBRL 8-K 26758
2 PRESS RELEASE DATED AUGUST 12, 2025 ex99_1.htm EX-99.1 1867
6 pr_1.jpg GRAPHIC 800921
7 pr_2.jpg GRAPHIC 898965
8 pr_3.jpg GRAPHIC 1261686
9 pr_4.jpg GRAPHIC 165358
  Complete submission text file 0001021771-25-000113.txt   4461569

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA brtx-20250812.xsd EX-101.SCH 3883
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20250812_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20250812_pre.xml EX-101.PRE 16056
19 EXTRACTED XBRL INSTANCE DOCUMENT brt81225_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 251206944
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)